TickerKhojComparison · NSE · data 2026-11-02
Bafna Pharmaceuticals Limited vs Lincoln Pharmaceuticals Ltd
In plain words
Size: Bafna Pharmaceuticals Limited is about 1.1 times the market value of Lincoln Pharmaceuticals Ltd.
Valuation (P/E): Bafna Pharmaceuticals Limited 136.1 vs Lincoln Pharmaceuticals Ltd 10.5.
Profit growth over 3 years: Lincoln Pharmaceuticals Ltd 6.4% a year vs Bafna Pharmaceuticals Limited -0.7% a year.
Debt to equity: Bafna Pharmaceuticals Limited 0.39 vs Lincoln Pharmaceuticals Ltd 0.01.
Differences in the numbers, not a recommendation of either stock.
Side by side
| BAFNAPH | LINCOLN | |
|---|---|---|
| Price | ₹447.9 | ₹506.15 |
| Market cap | ₹1,060 cr | ₹1,005 cr |
| P/E | 136.1 | 10.5 |
| P/B | — | — |
| ROE | 12.3% | 12.3% |
| ROCE | 9.2% | 10.9% |
| Debt / equity | 0.39 | 0.01 |
| Operating margin | 3.7% | 12.4% |
| Dividend yield | 0.00% | 0.36% |
| Sales growth, 3 years (yearly) | 9.3% | 9.4% |
| Profit growth, 3 years (yearly) | -0.7% | 6.4% |
| 1-year return | 218.1% | -4.9% |
| Revenue, last 12 months | ₹143 cr | ₹694 cr |
| Net profit, last 12 months | ₹8 cr | ₹96 cr |
| Latest quarter | Jun 2026 | Sept 2026 |
| Quarter net profit | ₹0 cr | ₹20 cr |
| Quarter profit vs a year earlier | -97.6% | +2.3% |
| Promoter holding | 75.00% | 49.78% |
| Health check | Average (4.5/10) | Strong (6.6/10) |
Common questions
Which has a higher P/E, Bafna Pharmaceuticals Limited or Lincoln Pharmaceuticals Ltd?
Bafna Pharmaceuticals Limited trades at the higher P/E (136.1 against 10.5). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Bafna Pharmaceuticals Limited (12.3% against 12.3%).
Which carries more debt?
Bafna Pharmaceuticals Limited has the higher debt-to-equity ratio (0.39 against 0.01).